Clinical efficacy of hepatic artery infusion chemotherapy combined with immunotherapy plus target therapy for advanced hepatocellular carcinoma
10.3760/cma.j.cn115610-20211104-00543
- VernacularTitle:肝动脉灌注化疗联合免疫靶向治疗在晚期肝细胞癌中的临床疗效
- Author:
Hongxiang CAO
1
;
Rui LIAO
;
Qiang HE
;
Long PAN
;
Yi ZHAO
;
Yongchen WANG
;
Junjie HUANG
;
Chenrui WU
;
Ruirui SUN
;
Ping HUANG
Author Information
1. 重庆医科大学附属第一医院肝胆外科 400016
- Keywords:
Liver neoplasms;
Hepatic artery infusion chemotherapy;
Targeted therapy;
Immunotherapy;
Systemic therapy
- From:
Chinese Journal of Digestive Surgery
2021;20(S2):41-44
- CountryChina
- Language:Chinese
-
Abstract:
Primary liver cancer is one of the common malignant tumors and its mortality ranks third in the world. Because there are no obvious symptoms in the early stage of liver cancer, most patients are diagnosed as advanced stage, without the opportunity of surgical resection. The authors report a case of hepatocellular carcinoma with portal vein tumor thrombus, which reduced significantly after hepatic artery infusion chemotherapy combined with bevacizumab and atezolizumab, showing the safety and efficacy.
